Table 2.
Subject characteristics
| Subjects (n = 38) |
Controls (n = 24) |
|
|---|---|---|
| Age (mean ± SD) | 42.0 ± 16.5 | 39.2 ± 15.2 |
| Male: Female | 1: 1.8 | 1: 1.5 |
| Migraine type after BP or YP | – | |
| •With aura | 26 (72%) | |
| •Without aura | 15 (42%) | |
| Mean age of onset (years) (±SD) | 17.8 ± 9.11 | – |
| Mean disease duration (years) (±SD) | 24.3 ± 16.7 | – |
| Treatment | – | |
| •Preventative | 8 (22%) | |
| •During attacks | ||
| Over the counter | 25 (69%) | |
| Triptans | 14 (39%) | |
| Opioids | 13 (36%) | |
| Ergot | 2 (6%) | |
| Mean attacks per month (±SD) | 2.62 ± 5.17 | – |
| Mean headache duration (hours) (±SD) | 11.75 ± 16.5 | – |
| Trigger | – | |
| •Light | 15 (41%) | |
| •Other | 32 (88%) | |
| Photophobia | 34 (94%) | – |